Today: 14 May 2026
Diageo stock rises as Kenyan court delays hearing on $2.3 billion EABL sale to Asahi
9 January 2026
1 min read

Diageo stock rises as Kenyan court delays hearing on $2.3 billion EABL sale to Asahi

LONDON, Jan 9, 2026, 10:46 GMT — Regular session

  • Diageo shares rose about 2% in London after a Kenyan court pushed a hearing on a bid to halt its EABL sale to Jan. 20
  • The $2.3 billion deal to sell Diageo’s 65% stake in East African Breweries to Asahi is facing a legal challenge from local distributor Bia Tosha
  • Investors are watching the Jan. 20 court date and Diageo’s Feb. 25 interim results for updates on cash, debt and demand

Diageo (DGE.L) shares rose on Friday after a Kenyan court postponed a hearing on a bid to block the drinks maker’s $2.3 billion sale of East African Breweries to Japan’s Asahi Holdings. The stock was up about 2% at 1,634 pence in mid-morning trade.

The case lands at a touchy moment for Diageo, which has been leaning on asset sales to bring in cash and curb debt. A delay in one of its bigger disposals would complicate that timetable.

Investors have also been watching whether spirits demand is steadying, particularly in the United States. That puts more weight on anything that shifts the company’s cash inflow, even if it is far from Diageo’s core markets.

Kenya’s High Court moved the hearing to Jan. 20. Judge Bahati Mwamuye said the parties could take preliminary steps such as regulatory approvals — sign-offs from watchdogs — but could not finalise the transaction before that date, and deal parties still expect completion in the second half of this year. 

The challenge was filed this week by beer distributor Bia Tosha over litigation dating back to 2016. East African Breweries, which is listed in Nairobi, said the case had no factual or legal link to the transaction and added that it and its Kenyan unit could defend any litigation; the sale values EABL at $4.8 billion and would leave Diageo with no direct stake in the African beer business. 

Diageo was last at 1,633.9 pence, up 1.99% on the day, after closing at 1,602.0 pence on Thursday. The stock fell 4.08% on Wednesday and hit an intraday low of 1,564.0 pence, near the bottom of its 52-week range. 

The broader FTSE 100 was up about 0.4% on the session. 

But the legal fight is not over. A tougher ruling, or a longer timetable, could still slow the deal and push out cash proceeds at a time when investors want clearer signs on debt reduction and sales momentum.

The next court hearing is due Jan. 20. Diageo is scheduled to report interim results on Feb. 25, when investors will look for updates on U.S. demand, tariffs and cash generation. 

Stock Market Today

  • Cerebras Prices IPO Above Range, Raises $5.55 Billion Amid AI Market Surge
    May 13, 2026, 6:50 PM EDT. Cerebras Systems, an artificial intelligence chipmaker, priced its initial public offering (IPO) at $185 per share, raising at least $5.55 billion, exceeding expectations. The IPO values the company at $56.4 billion on a fully diluted basis. Founder and CEO Andrew Feldman's stake is now worth about $1.9 billion. The company, facing scrutiny over reliance on a UAE customer, has diversified its revenue sources and pivoted towards cloud services. Cerebras secured a $20 billion deal with OpenAI for its computing capacity, competing against major cloud providers like Google and Microsoft. The IPO marks one of the largest tech public offerings in recent years, signaling strong investor interest amid a broad surge in semiconductor stocks fueled by AI technology demand.

Latest articles

Hewlett Packard Enterprise Stock Jumps as Activist Investors Circle Its AI Networking Pivot

Hewlett Packard Enterprise Stock Jumps as Activist Investors Circle Its AI Networking Pivot

14 May 2026
Hewlett Packard Enterprise shares jumped 6% Wednesday after Semafor reported new activist investors, including Irenic Capital, had taken stakes, joining Elliott Management. The stock closed at $32.07, giving HPE a market value of $43.5 billion on heavy volume. HPE is integrating Juniper and launching new private-cloud tools for AI workloads. The company’s next earnings call is set for June 1.
KULR Stock Jumps as 300-Bitcoin Coinbase Transfer Tests Its Treasury Bet

KULR Stock Jumps as 300-Bitcoin Coinbase Transfer Tests Its Treasury Bet

14 May 2026
KULR Technology Group deposited 300 bitcoin, valued at $24.36 million, into Coinbase Prime, according to Lookonchain, sparking speculation of a possible sale. KULR shares jumped 26.8% to $4.05 on heavy volume. The company, which holds over 1,000 bitcoin, widened its Q4 net loss to $44.3 million, citing a $28.3 million mark-to-market loss on Bitcoin. KULR reports Q1 results Thursday.
Aeluma Stock Swings After Q3 Loss as AI Photonics Bet Faces Revenue Delay

Aeluma Stock Swings After Q3 Loss as AI Photonics Bet Faces Revenue Delay

14 May 2026
Aeluma Inc. shares fell 16.3% to $26.35 in after-hours trading Wednesday after the company narrowed its 2026 revenue outlook and posted a $1.8 million quarterly loss. Revenue for the quarter ended March 31 was $1.2 million, missing estimates. The company cited delayed contracts and government shutdowns. Cash stood at $37.8 million at quarter’s end.
Allegiant Just Bought Sun Country. Here’s What Happens to Flights, Rewards and Stock Now

Allegiant Just Bought Sun Country. Here’s What Happens to Flights, Rewards and Stock Now

14 May 2026
Allegiant Travel closed its acquisition of Sun Country Airlines on May 13, making Sun Country a wholly owned subsidiary and ending its status as a standalone public company. Each Sun Country share was converted into $4.10 in cash and 0.1557 Allegiant shares. Allegiant now operates a combined fleet of 195 aircraft serving nearly 175 cities. Sun Country asked Nasdaq to suspend trading and begin delisting.
DroneShield (ASX:DRO) stock jumps after Trump defense-budget push — what investors watch next
Previous Story

DroneShield (ASX:DRO) stock jumps after Trump defense-budget push — what investors watch next

GSK stock slips in London as hepatitis B drug details awaited; Feb 4 results loom
Next Story

GSK stock slips in London as hepatitis B drug details awaited; Feb 4 results loom

Go toTop